SCHEMBL26159160

SCHEMBL26159160

COC(=O)C1CCN(S(=O)(=O)c2ccc(C)cc2)c2cc(Cl)ccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ HPGD P15428 1/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ MAPT P10636 5/20 0.42
▸ MMP2 P08253 1/20 0.42
▸ ANPEP P15144 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ POLB P06746 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NSD2 O96028 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ FKBP1A P62942 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26159159 0.90 KMT2A (0.50) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL17158242 0.85 KCNN4 (0.50) ALDH1A1KDM4ELMNAHPGDKMT2A
SCHEMBL1292014 0.82 ALDH1A1 (0.48) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL16723452 0.82 MAPT (0.43) ALDH1A1KDM4ELMNAHPGDKMT2A
SCHEMBL22578028 0.80 ALDH1A1 (0.52) ALDH1A1KDM4ELMNAHPGDKMT2A
SCHEMBL4781373 0.77 KMT2A (0.48) ALDH1A1KDM4ELMNAHPGDKMT2A
SCHEMBL2570325 0.76 ALDH1A1 (0.52) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL4726759 0.75 HTR6 (0.50) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL26159157 0.73 MAPT (0.51) LMNAKMT2AMEN1MAPTMMP2
SCHEMBL25429745 0.73 ALDH1A1 (0.48) ALDH1A1LMNAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159463-A1 BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI ZHONGZE THERAPEUTICS, CO. LTD. (CN) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159463-A1 BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HDAC11, HDAC1, HDAC6 ALDH1A1 164/4885KDM4E 1120/4885LMNA 2388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback